Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
0.6700
-0.0001 (-0.01%)
At close: Jan 16, 2026, 4:00 PM EST
0.6809
+0.0109 (1.63%)
After-hours: Jan 16, 2026, 7:49 PM EST
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $4.28 million as of January 16, 2026. Its market cap has decreased by -54.18% in one year.
Market Cap
4.28M
Enterprise Value
-2.87M
1-Year Change
-54.18%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $4.28M, a decrease of -98.68%. That is a compound annual growth rate of -65.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 4.28M | 203.49% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
| Dec 10, 2021 | 323.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |